Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-25-272465
Filing Date
2025-11-07
Accepted
2025-11-07 16:34:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A d56842ds3a.htm S-3/A 423770
2 EX-5.1 d56842dex51.htm EX-5.1 25635
3 EX-23.2 d56842dex232.htm EX-23.2 2064
4 EX-23.3 d56842dex233.htm EX-23.3 2120
5 GRAPHIC g56842g03x03.jpg GRAPHIC 46817
  Complete submission text file 0001193125-25-272465.txt   519453
Mailing Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301
Business Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-289748 | Film No.: 251463176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)